Search research articles
Contact Us
Filters
Showing results (381-390 of 401) with videos related to
Page
of 41
Sort By:
The Journal of Infectious Diseases
|
June 25, 2014
Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial
Krystle A Lang Kuhs, Paula Gonzalez, Ana Cecilia Rodriguez, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian, Joshua N Sampson, Yuanji Pan, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H Tsang, Joshua N Sampson, John Schussler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA
Shari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Microbiology Spectrum
|
January 12, 2022
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays
Ligia A Pinto, Ribhi M Shawar, Brendan O'Leary, et al.
American Journal of Epidemiology
|
August 21, 2014
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates
Krystle A Lang Kuhs, Carolina Porras, John T Schiller, et al.
The Journal of Infectious Diseases
|
September 10, 2013
Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica
Krystle A Lang Kuhs, Paula Gonzalez, Linda Struijk, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Aimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Journal of the National Cancer Institute
|
May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial
Shang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.
The Lancet. Oncology
|
December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 401) with videos related to
Sort By:
Page
of 41
The Journal of Infectious Diseases
|
June 25, 2014
Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial
Krystle A Lang Kuhs, Paula Gonzalez, Ana Cecilia Rodriguez, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Mahboobeh Safaeian, Joshua N Sampson, Yuanji Pan, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H Tsang, Joshua N Sampson, John Schussler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA
Shari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Microbiology Spectrum
|
January 12, 2022
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays
Ligia A Pinto, Ribhi M Shawar, Brendan O'Leary, et al.
American Journal of Epidemiology
|
August 21, 2014
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates
Krystle A Lang Kuhs, Carolina Porras, John T Schiller, et al.
The Journal of Infectious Diseases
|
September 10, 2013
Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica
Krystle A Lang Kuhs, Paula Gonzalez, Linda Struijk, et al.
Journal of the National Cancer Institute
|
February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Aimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Journal of the National Cancer Institute
|
May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial
Shang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.
The Lancet. Oncology
|
December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Page
of 41